Literature DB >> 19506969

Testing for CYP2C9 before initiating anticoagulant therapy.

Oscar M P Jolobe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19506969      PMCID： PMC2710480          DOI： 10.1007/s11606-009-1041-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  8 in total

1.  Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.

Authors:  Oscar M Jolobe
Journal:  J Am Geriatr Soc       Date:  2008-10       Impact factor: 5.562

2.  Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

Authors:  J Rosand; E M Hylek; H C O'Donnell; S M Greenberg
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

3.  Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.

Authors:  E E Smith; J Rosand; K A Knudsen; E M Hylek; S M Greenberg
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

4.  Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes
Journal:  J Am Coll Cardiol       Date:  2009-05-12       Impact factor: 24.094

Review 5.  Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review.

Authors:  Amit Noheria; Abhishek Kumar; John V Wylie; Mark E Josephson
Journal:  Arch Intern Med       Date:  2008-03-24

6.  Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke.

Authors:  H Ueno; H Naka; T Ohshita; K Kondo; E Nomura; T Ohtsuki; T Kohriyama; S Wakabayashi; M Matsumoto
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

7.  Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?

Authors:  Mark H Eckman; Steven M Greenberg; Jonathan Rosand
Journal:  J Gen Intern Med       Date:  2009-03-03       Impact factor: 5.128

8.  Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis.

Authors:  James F Doyle; Kwok M Ho
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.